FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to the use of a compound 2-Hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]-1H-indole-5-carbonitrile as a drug having anti-clonogenic activity against human tumor cells.
EFFECT: implementation of the invention provides suppression of the clonogenicity of human tumor cells.
1 cl, 1 ex, 6 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF REDUCING THE NUMBER OF STEM CELLS OF HUMAN BREAST ADENOCARCINOMA | 2022 |
|
RU2798550C2 |
METHOD FOR REDUCING CLONOGENIC ACTIVITY OF LACTEAL GLAND CANCER STEM CELLS | 2019 |
|
RU2700695C2 |
COMPOSITION FOR PREVENTING CHEMORESISTANCE TO ANTIMITOTIC AGENTS | 2022 |
|
RU2807691C1 |
METHOD OF STRENGTHENING CYTOTOXIC EFFECTS OF PANOBINOSTAT ON TUMOR CELLS | 2023 |
|
RU2806371C2 |
METHOD FOR DETERMINING THE REDUCTION OF RADIATION-INDUCED MIGRATION OF HUMAN BREAST CANCER CELLS OF THE MCF-7 LINE | 2022 |
|
RU2789099C2 |
TEST SYSTEM FOR HUMAN PROTEIN KINASE GSK3β INHIBITOR SCREENING | 2012 |
|
RU2528059C2 |
METHOD OF INHIBITING RADIATION-INDUCED INCREASE IN HUMAN BREAST CANCER STEM CELLS | 2022 |
|
RU2800366C2 |
N-[3-OXOLUP-20(29)-ENE-28-OIL]-2,2,6,6-TETRAMETHYLPIPERIDINE-4-YLAMINE WITH CYTOTOXIC ACTIVITY IN RESPECT OF HUMAN TUMOUR CELLS | 2017 |
|
RU2641900C1 |
METHOD OF FLUORESCENCE IMMUNOASSAY OF OESTROGEN β RECEPTORS IN HUMAN SOLID TUMOURS | 2010 |
|
RU2429481C1 |
METHOD FOR IMMUNOFLUORESCENCE ASSAY OF EXCISION REPAIR PROTEIN ERCC1 IN HUMAN SOLID TUMOURS | 2014 |
|
RU2563116C1 |
Authors
Dates
2018-03-28—Published
2016-04-14—Filed